Amy D' Rix, Interim CEO, Founder

1
Inc.
Amy D. Rix, Interim CEO, Founder
Stop the Bleed with NOseBLEED
2
Social/Public Issues

• Problems that can be associated with frequent
  nosebleeds
• Embarrassing especially when out in public
• Loss of dignity
• Loss of clothes
• Having to stop what you are doing
• Loss of time in a game (sports)

3
Solution Stop the bleed with
NOseBLEEDTM

• Benefits of NOseBLEED
• Is non-invasive to the nose
• Does not restrict normal breathing
• Stops nosebleeds in 1-2 minutes
• Product is digestible

Technology
Technology
Technology
Technology
Technology
4
Sizable Need

• 2003 Study 440 million total US nosebleeds per
  year
• Benninger and Marple - medical study
  (published/peer reviewed)
• 2008 Market Research Study- 700 million recurrent
  (more than 1 per month) nosebleeds per year
• Leading online survey company

Market
Market
5
Business Model/Exit

• Contract Manufacturing
• Joint-venture distributors
• Cardinal Health
• McKesson
• Direct sales model
• Breathe Right Strips (CNS Inc.)
• DURABOND (Closure Medical Corp.)
• Partner and Exit Options
• CPC Licensing/Acquisition Options
• Johnson Johnson (Closure Medical Corp.,
  DURABOND)
• GSK
• Medical Supply Licensing/Acquisition Options
• McKesson
• Cardinal Health

Business
Business
6
Financial Return
Financials
7
Value Creation

• Seed Round Milestones
• Regulatory opinions -
• Prototypes
• Material selection
• Market research
• Segment strategy -
• FDA approval Ongoing
• Manufacturing partner(s) Ongoing
• Sterilization process Ongoing
• 350K

• Series A Milestones
• 100 million revenue
• Cash flow positive
• Partner agreement and exit
• IP Continuation
• 2.5 Million

Financials
Milestones